This document serves as a notice of trademark registration for "SHIELD TECHNOLOGY" by the USPTO. The trademark covers medical devices, specifically an antithrombogenic treated neurovascular stent designed to reduce thrombogenicity. The registration was finalized on March 20, 2026, with the initial application filed on October 31, 2014.

For companies operating in the medical device sector, this registration signifies exclusive rights for the mark "SHIELD TECHNOLOGY" within its specified class. While this is a routine trademark registration notice and not a regulatory rule, it highlights the importance of intellectual property protection for medical device innovations. Compliance officers should ensure their company's branding and product names do not infringe on registered trademarks.